Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 838 shares at $6.85 ($6K) on 2020-09-21, disclosed to the SEC on 2020-09-23.
Seasonal sale ($6k) by See Remarks — this insider has traded CLVS in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.85 | 829 | $6K | 98.9% |
| 2 | $6.86 | 9 | $62 | 1.1% |
| Total | $6.85 avg | 838 | $6K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |